Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: October 31, 2008
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):